Human TIM-3/HAVCR2 PicoKine ELISA Kit
To Order Contact us: [email protected]
Human TIMP-1 PicoKine ELISA Kit |
|||
EK0520 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human TIMP-1 in cell culture supernates, serum, plasma(heparin, EDTA) and saliva. |
Human TIMP-2 PicoKine ELISA Kit |
|||
EK0522 | BosterBio | 96 wells | EUR 523.2 |
Description: For quantitative detection of human TIMP-2 in cell culture supernates, serum, plasma(heparin , EDTA) and saliva. |
Human TIMP-4 PicoKine ELISA Kit |
|||
EK0524 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human TIMP-4 in cell culture supernates, serum, plasma(heparin, EDTA) and human milk. |
TIM-3 Antibody / HAVCR2 |
|||
RQ4354 | NSJ Bioreagents | 100 ug | EUR 356.15 |
Description: Hepatitis A virus cellular receptor 2 (HAVCR2), also known as T-cell immunoglobulin and mucin-domain containing-3 (TIM-3), is a protein that in humans is encoded by the HAVCR2 gene. The protein encoded by this gene belongs to the immunoglobulin superfamily, and TIM family of proteins. CD4-positive T helper lymphocytes can be divided into types 1 (Th1) and 2 (Th2) on the basis of their cytokine secretion patterns. Th1 cells are involved in cell-mediated immunity to intracellular pathogens and delayed-type hypersensitivity reactions, whereas, Th2 cells are involved in the control of extracellular helminthic infections and the promotion of atopic and allergic diseases. This protein is a Th1-specific cell surface protein that regulates macrophage activation, and inhibits Th1-mediated auto- and alloimmune responses, and promotes immunological tolerance. |
TIM-3 Antibody / HAVCR2 |
|||
V9177-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cell tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V9177-20UG | NSJ Bioreagents | 20ug | EUR 153.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cell tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V9177SAF-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cell tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
R20463-0.1ML | NSJ Bioreagents | 100ul | EUR 409 |
TIM-3 Antibody / HAVCR2 |
|||
V7533-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: The protein encoded by the HAVCR2 gene belongs to the immunoglobulin superfamily, and TIM family of proteins. CD4-positive T helper lymphocytes can be divided into types 1 (Th1) and 2 (Th2) on the basis of their cytokine secretion patterns. Th1 cells are involved in cell-mediated immunity to intracellular pathogens and delayed-type hypersensitivity reactions, whereas, Th2 cells are involved in the control of extracellular helminthic infections and the promotion of atopic and allergic diseases. This protein is a Th1-specific cell surface protein that regulates macrophage activation, and inhibits Th1-mediated auto- and alloimmune responses, and promotes immunological tolerance. [RefSeq] |
TIM-3 Antibody / HAVCR2 |
|||
V7533-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: The protein encoded by the HAVCR2 gene belongs to the immunoglobulin superfamily, and TIM family of proteins. CD4-positive T helper lymphocytes can be divided into types 1 (Th1) and 2 (Th2) on the basis of their cytokine secretion patterns. Th1 cells are involved in cell-mediated immunity to intracellular pathogens and delayed-type hypersensitivity reactions, whereas, Th2 cells are involved in the control of extracellular helminthic infections and the promotion of atopic and allergic diseases. This protein is a Th1-specific cell surface protein that regulates macrophage activation, and inhibits Th1-mediated auto- and alloimmune responses, and promotes immunological tolerance. [RefSeq] |
TIM-3 Antibody / HAVCR2 |
|||
V7533IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: The protein encoded by the HAVCR2 gene belongs to the immunoglobulin superfamily, and TIM family of proteins. CD4-positive T helper lymphocytes can be divided into types 1 (Th1) and 2 (Th2) on the basis of their cytokine secretion patterns. Th1 cells are involved in cell-mediated immunity to intracellular pathogens and delayed-type hypersensitivity reactions, whereas, Th2 cells are involved in the control of extracellular helminthic infections and the promotion of atopic and allergic diseases. This protein is a Th1-specific cell surface protein that regulates macrophage activation, and inhibits Th1-mediated auto- and alloimmune responses, and promotes immunological tolerance. [RefSeq] |
TIM-3 Antibody / HAVCR2 |
|||
V7533SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: The protein encoded by the HAVCR2 gene belongs to the immunoglobulin superfamily, and TIM family of proteins. CD4-positive T helper lymphocytes can be divided into types 1 (Th1) and 2 (Th2) on the basis of their cytokine secretion patterns. Th1 cells are involved in cell-mediated immunity to intracellular pathogens and delayed-type hypersensitivity reactions, whereas, Th2 cells are involved in the control of extracellular helminthic infections and the promotion of atopic and allergic diseases. This protein is a Th1-specific cell surface protein that regulates macrophage activation, and inhibits Th1-mediated auto- and alloimmune responses, and promotes immunological tolerance. [RefSeq] |
TIM-3 Antibody / HAVCR2 |
|||
V7582-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V7582-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V7582IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V7582SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8495-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8495-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8495SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8724-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8724-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8724SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8753-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8753-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8753SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8754-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8754-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8754SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8755-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8755-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8755SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8766-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+ Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8766-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+ Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|||
V8766SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+ Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
Human IL-3 PicoKine ELISA Kit |
|||
EK0402 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human IL-3 in cell culture supernates, serum and plasma( heparin, EDTA, citrate). |
Human DKK-3 PicoKine ELISA Kit |
|||
EK1323 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human DKK-3 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Human MMP-3 PicoKine ELISA Kit |
|||
EK0461 | BosterBio | 96 wells | EUR 523.2 |
Description: For quantitative detection of human MMP-3 in cell culture supernates, serum and plasma (heparin). |
Human ICAM-3 PicoKine ELISA Kit |
|||
EK0940 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human ICAM-3 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Human IGFBP-3 PicoKine ELISA Kit |
|||
EK0386 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human IGFBP-3 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Human Relaxin 3 PicoKine ELISA Kit |
|||
EK1407 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human Relaxin 3 in cell culture supernates, serum and plasma( heparin). |
Human Caspase 3 PicoKine ELISA Kit |
|||
EK1425 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human Caspase 3 in cell culture supernate sand serum. |
Human Ficolin-3 PicoKine ELISA Kit |
|||
EK1259 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human Ficolin-3 in cell culture supernates, serum and plasma(heparin). |
Human Matrilin-3 PicoKine ELISA Kit |
|||
EK2022 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human Matrilin-3 in cell culture supernates, serum and plasma (heparin, EDTA). |
Human Kallikrein 3 PicoKine ELISA Kit |
|||
EK0816 | BosterBio | 96 wells | EUR 547.2 |
Description: For quantitative detection of Human Kallikrein 3 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Human CCL7/MCP-3 PicoKine ELISA Kit |
|||
EK0443 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human CCL7 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Human Neurotrophin-3 PicoKine ELISA Kit |
|||
EK0472 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human Neurotrophin-3 in cell culture supernates and serum. |
Human TGF-beta 3 PicoKine ELISA Kit |
|||
EK1103 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of activated human TGF-beta 3 in cell culture supernates, serum, plasma(EDTA) and urine. |
Human MPO PicoKine ELISA Kit |
|||
EK0850 | BosterBio | 96 wells | EUR 547.2 |
Description: For quantitative detection of human MPO in cell culture supernates, cell lysate, serum, plasma(heparin, EDTA), saliva and urine. |
Human P53 PicoKine ELISA Kit |
|||
EK0895 | BosterBio | 96 wells | EUR 571.2 |
Description: For quantitative detection of human P53 in cell lysates. |
Human CEA PicoKine ELISA Kit |
|||
EK0904 | BosterBio | 96 wells | EUR 583.2 |
Description: For quantitative detection of human CEA in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Human MIA PicoKine ELISA Kit |
|||
EK0941 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human MIA in cell culture supernates, serum, plasma(heparin, EDTA) and saliva. |
Human CFD PicoKine ELISA Kit |
|||
EK1199 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human CFD in cell culture supernates, serum, plasma(heparin , EDTA) and urine. |
Human LBP PicoKine ELISA Kit |
|||
EK1271 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human LBP in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Human CRP PicoKine ELISA Kit |
|||
EK1316 | BosterBio | 96 wells | EUR 546 |
Description: For quantitative detection of human CRP in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Human ADA PicoKine ELISA Kit |
|||
EK1446 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human ADA in cell culture supernates, serum and pleural fluid. |
Human IDS PicoKine ELISA Kit |
|||
EK1452 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human IDS in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Human GHR PicoKine ELISA Kit |
|||
EK1467 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human GHR in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Human HE4 PicoKine ELISA Kit |
|||
EK1469 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human HE4 in cell culture supernates, serum, plasma(heparin, EDTA), saliva, urine and human milk. |
Human B2M PicoKine ELISA Kit |
|||
EK1691 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human B2M in cell culture supernates, serum, plasma (heparin, EDTA), saliva, urine and human milk. |
Human PAM PicoKine ELISA Kit |
|||
EK1765 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human PAM in cell culture supernates, serum and plasma (heparin, EDTA, citrate). |
Human EDA PicoKine ELISA Kit |
|||
EK1856 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human EDA in cell culture supernates, serum and plasma (heparin, EDTA). |
Human PZP PicoKine ELISA Kit |
|||
EK1873 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human PZP in cell culture supernates, serum and plasma (heparin, EDTA). |
Human RET PicoKine ELISA Kit |
|||
EK1877 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human RET in cell culture supernates, serum and plasma (heparin). |
Human CPE PicoKine ELISA Kit |
|||
EK1887 | BosterBio | 96 wells | EUR 510 |
Description: For quantitative detection of human CPE in For quantitative detection of human CPE in cell culture supernates, serum and plasma (heparin, EDTA). |